Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer

Part of paid clinical trials in Aurora, Colorado.

Sponsor
University of Colorado, Denver
Study ID
NCT01580982
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Study Details

The mechanisms of sensitivity and resistance to oncogene-targeted therapy can be determined from tumor tissue or tumor cell lines derived from available archival samples and/or from standard-of-care re-biopsy upon suspected tumor progression.

Key Dates

Start date
Jan 23, 2012
Status verified
Feb 2026
Primary completion
Jan 1, 2028
Completion
Jan 30, 2029

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

To identify baseline and treatment-related somatic changes in the tumor tissue from patients with lung and other thoracic cancers. [ Time Frame: To be determined upon funding ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Colorado Cancer CenterAuroraColorado80045
Brandi Kubala
[email protected]
303-724-1657
Erin Schenk, MD,Ph.D (PRINCIPAL_INVESTIGATOR)

Find similar trials in Aurora, CO

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
University of Colorado Cancer Center· Aurora, CO

Related Studies